EETs administration decreased adiposity and insulin resistance in mice and rat models of obesity and diabetes via an increase in HO-1 gene expression and signaling cascade including the activation of AMPK and pAKT [72–74]. The gene discussed is HMOX1; the disease is obesity disorder.